EMAIL THIS PAGE TO A FRIEND

Nanotechnology

A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma.


PMID 25074670

Abstract

One of the major drawbacks that limits the clinical application of nanoparticles is the lack of preliminary investigations related to their biocompatibility, biodegradability and biodistribution. In this work, biodegradable PEGylated polymer nanoparticles (NPs) have been synthesized by using macromonomers based on poly(ε-caprolaconte) oligomers. More in detail, NPs have been produced by adopting a surfactant-free semibatch emulsion polymerization process using PEG chains as a stabilizing agent. The NPs were also labeled with rhodamine B covalently bound to the NPs to quantitatively study their biodistribution in vivo. NPs were investigated in both in vitro and in vivo preclinical systems to study their biodistribution in mice bearing B16/F10 melanoma, as well as their biocompatibility and biodegradability. The NP concentration was evaluated in different tissues at several times after intravenous injection. The disappearance of the NPs from the plasma was biphasic, with distribution and elimination half-lives of 30 min and 15 h, respectively. NPs were retained in tumors and in filter organs for a long time, were still detectable after 7 d and maintained a steady concentration in the tumor for 120 h. 48 h after injection, 70 ± 15% of the inoculated NPs were excreted in the feces. The favorable tumor uptake, fast excretion and absence of cytotoxicity foster the further development of produced NPs as drug delivery carriers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

17348
2-Hydroxyethyl methacrylate, embedding medium (for microscopy)
C6H10O3
477028
2-Hydroxyethyl methacrylate, ≥99%, contains ≤50 ppm monomethyl ether hydroquinone as inhibitor
C6H10O3
128635
2-Hydroxyethyl methacrylate, contains ≤250 ppm monomethyl ether hydroquinone as inhibitor, 97%
C6H10O3
107700
4-(Dimethylamino)pyridine, ReagentPlus®, ≥99%
C7H10N2
39405
4-(Dimethylamino)pyridine, purum, ≥98.0% (NT)
C7H10N2
714844
4-(Dimethylamino)pyridine solution, 0.5 M in THF
C7H10N2
714720
4-(Dimethylamino)pyridine solution, 0.5 M in ethyl acetate
C7H10N2
700169
4-(Dimethylamino)pyridine, ChemDose tablets, Loading: 0.04 mmol tablet.
C7H10N2
379115
DCC, 1.0 M in methylene chloride
C13H22N2
36650
DCC, puriss., ≥99.0% (GC)
C13H22N2
D80002
DCC, 99%
C13H22N2
633267
Dicyclohexylcarbodiimide solution, 60 wt. % in xylenes
C13H22N2
236705
Pentane, anhydrous, ≥99%
C5H12
34956
Pentane, for HPLC, ≥99.0%
C5H12
154954
Pentane, spectrophotometric grade, ≥99%
C5H12
158941
Pentane, reagent grade, 98%
C5H12
76870
Pentane, analytical standard
C5H12
76871
Pentane, puriss. p.a., ≥99.0% (GC)
C5H12
60489
Pentane, ≥99% (GC)
C5H12
76874
Pentane, purum, ≥95.0% (GC)
C5H12
442746
Pentane, analytical standard
C5H12
P5592
Potassium peroxodisulfate, BioXtra, ≥99.0%
K2O8S2
60489
Potassium peroxodisulfate, puriss. p.a., ACS reagent, ≥99.0% (RT)
K2O8S2
379824
Potassium persulfate, 99.99% trace metals basis
K2O8S2
216224
Potassium persulfate, ACS reagent, ≥99.0%
K2O8S2
R6626
Rhodamine B, ≥95% (HPLC)
C28H31ClN2O3
83689
Rhodamine B, for fluorescence
C28H31ClN2O3
79754
Rhodamine B, analytical standard
C28H31ClN2O3
02558
Rhodamine B solution, 0.2% in isopropanol, for TLC derivatization
C28H31ClN2O3
S3252
Tin(II) 2-ethylhexanoate, 92.5-100.0%
C16H30O4Sn